Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection

Journal of Experimental Medicine

Volumn 202, Issue 5, 2005, Pages 637-650

  Kolumam, Ganesh A ^a   Thomas, Sunil ^a   Thompson, Lucas J ^a   Sprent, Jonathan ^b   Murali Krishna, Kaja ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; INTERFERON RECEPTOR;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EFFECTOR CELL; MEMORY CELL; MOUSE; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; REDUCTION; T LYMPHOCYTE; VIRUS INFECTION; VIRUS MENINGITIS; WILD TYPE;

ANIMALS; ARENAVIRIDAE INFECTIONS; CD8-POSITIVE T-LYMPHOCYTES; FLUORESCEINS; IMMUNOLOGIC MEMORY; INTERFERON TYPE I; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION; SUCCINIMIDES;

EID: 24344478196     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20050821     Document Type: Article

References (53)

1. Murali-Krishna, K., J.D. Altman, M. Suresh, D.J. Sourdive, A.J. Zajac, J. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 8:177-187.
2. Kaech, S.M., E.J. Wherry, and R. Ahmed. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2:251-262.
3. Cousens, L.P., R. Peterson, S. Hsu, A. Dorner, J.D. Altman, R. Ahmed, and C.A. Biron. 1999. Two roads diverged: interferon α/β-and interleukin 12-mediated pathways in promoting T cell interferon γ responses during viral infection. J. Exp. Med. 189:1315-1328.
4. Hochrein, H., K. Shortman, D. Vremec, B. Scott, P. Hertzog, and M. O'Keeffe. 2001. Differential production of IL-12, IFN-α, and IFN-γ by mouse dendritic cell subsets. J. Immunol. 166:5448-5456.
5. Stark, G.R., I.M. Kerr, B.R. Williams, R.H. Silverman, and R.D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
6. Luft, T., K.C. Pang, E. Thomas, P. Hertzog, D.N. Hart, J. Trapani, and J. Cebon. 1998. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161:1947-1956.
7. Biron, C.A. 2001. Interferons alpha and beta as immune regulators-a new look. Immunity. 14:661-664.
8. Le Bon, A., N. Etchart, C. Rossmann, M. Ashton, S. Hou, D. Gewert, P. Borrow, and D.F. Tough. 2003. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat. Immunol. 4:1009-1015.
9. Krug, A., R. Veeraswamy, A. Pekosz, O. Kanagawa, E.R. Unanue, M. Colonna, and M. Cella. 2003. Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells. J. Exp. Med. 197:899-906.
10. Parronchi, P., M. De Carli, R. Manetti, C. Simonelli, S. Sampognaro, M.P. Piccinni, D. Macchia, E. Maggi, G. Del Prete, and S. Romagnani. 1992. IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J. Immunol. 149:2977-2983.
11. Wenner, C.A., M.L. Guler, S.E. Macatonia, A. O'Garra, and K.M. Murphy. 1996. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. J. Immunol. 156:1442-1447.
12. Marrack, P., J. Kappler, and T. Mitchell. 1999. Type I interferons keep activated T cells alive. J. Exp. Med. 189:521-530.
13. Nguyen, K.B., W.T. Watford, R. Salomon, S.R. Hofmann, G.C. Pien, A. Morinobu, M. Gadina, J.J. O'Shea, and C.A. Biron. 2002. Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science. 297:2063-2066.
14. Marrack, P., and J. Kappler. 2004. Control of T cell viability. Annu. Rev. Immunol. 22:765-787.
15. Curtsinger, J.M., J.O. Valenzuela, P. Agarwal, D. Lins, and M.F. Mescher. 2005. Cutting edge: type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174:4465-4469.
16. Muller, U., U. Steinhoff, L.F. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science. 264:1918-1921.
17. Ou, R., S. Zhou, L. Huang, and D. Moskophidis. 2001. Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J. Virol. 75:8407-8423.
18. Dikopoulos, N., A. Bertoletti, A. Kroger, H. Hauser, R. Schirmbeck, and J. Reimann. 2005. Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells. J. Immunol. 174:99-109.
19. Zimmerman, C., K. Brduscha-Riem, C. Blaser, R.M. Zinkernagel, and H. Pircher. 1996. Visualization, characterization, and turnover of CD8 memory T cells in virus-infected hosts. J. Exp. Med. 183:1367-1375.
20. Murali-Krishna, K., L.L. Lau, S. Sambhara, F. Lemonnier, J. Altman, and R. Ahmed. 1999. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science. 286:1377-1381.
21. Homann, D., D.B. McGavern, and M.B. Oldstone. 2004. Visualizing the viral burden: phenotypic and functional alterations of T cells and APCs during persistent infection. J. Immunol. 172:6239-6250.
22. Rambukkana, A., S. Kunz, J. Min, K.P. Campbell, and M.B. Oldstone. 2003. Targeting Schwann cells by nonlytic arenaviral infection selectively inhibits myelination. Proc. Natl. Acad. Sci. USA. 100:16071-16076.
23. Kagi, D., and H. Hengartner. 1996. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr. Opin. Immunol. 8:472-477.
24. + T cells in persistent infection with lymphocytic choriomeningitis virus. J. Exp. Med. 187:1903-1920.
25. McNally, J.M., and R.M. Welsh. 2002. Bystander T cell activation and attrition. Curr. Top. Microbiol. Immunol. 263:29-41.
26. Harrington, L.E., M. Galvan, L.G. Baum, J.D. Altman, and R. Ahmed. 2000. Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans. J. Exp. Med. 191:1241-1246.
27. Kaech, S.M., and R. Ahmed. 2001. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2:415-422.
28. Badovinac, V.P., B.B. Porter, and J.T. Harty. 2002. Programmed contraction of CD8(+) T cells after infection. Nat. Immunol. 3:619-626.
29. van Stipdonk, M.J., G. Hardenberg, M.S. Bijker, E.E. Lemmens, N.M. Droin, D.R. Green, and S.P. Schoenberger. 2003. Dynamic programming of CD8+ T lymphocyte responses. Nat. Immunol. 4:361-365.
30. Kaech, S.M., J.T. Tan, E.J. Wherry, B.T. Konieczny, C.D. Surh, and R. Ahmed. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4:1191-1198.
31. Liu, N., T. Phillips, M. Zhang, Y. Wang, J.T. Opferman, R. Shah, and P.G. Ashton-Rickardt. 2004. Serine protease inhibitor 2A is a protective factor for memory T cell development. Nat. Immunol. 5:919-926.
32. Madakamutil, L.T., U. Christen, C.J. Lena, Y. Wang-Zhu, A. Attinger, M. Sundarrajan, W. Ellmeier, M.G. von Herrath, P. Jensen, D.R. Littman, and H. Cheroutre. 2004. CD8 alpha alpha-mediated survival and differentiation of CD8 memory T cell precursors. Science. 304:590-593.
33. Kaech, S.M., S. Hemb, E. Kersh, and R. Ahmed. 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell. 111:837-851.
34. Biron, C.A., K.B. Nguyen, and G.C. Pien. 2002. Innate immune responses to LCMV infections: natural killer cells and cytokines. Curr. Top. Microbiol. Immunol. 263:7-27.
35. Constantinescu, S.N., E. Croze, A. Murti, C. Wang, L. Basu, D. Hollander, D. Russell-Harde, M. Betts, V. Garcia-Martinez, and J.E. Mullersman. 1995. Expression and signaling specificity of the IFNAR chain of the type I interferon receptor complex. Proc. Natl. Acad. Sci. USA. 92:10487-10491.
36. Ito, K., H. Tanaka, T. Ito, T.A. Sultana, T. Kyo, F. Imanaka, Y. Ohmoto, and A. Kimura. 2004. Initial expression of interferon alpha receptor 2 (IFNAR2) on CD34-positive cells and its down-regulation correlate with clinical response to interferon therapy in chronic myelogenous leukemia. Eur. J. Haematol. 73:191-205.
37. Welsh, R.M., L.K. Selin, and E. Szomolanyi-Tsuda. 2004. Immunological memory to viral infections. Annu. Rev. Immunol. 22:711-743.
38. D'Souza, W.N., and L. Lefrancois. 2003. IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion. J. Immunol. 171:5727-5735.
39. Wong, P., and E.G.P. Am. 2004. Disparate in vitro and in vivo requirements for IL-2 during antigen-independent CD8 T cell expansion. J. Immunol. 172:2171-2176.
40. Whitmire, J.K., J.T. Tan, and J.L. Whitton. 2005. Interferon-γ acts directly on CD8+ T cells to increase their abundance during virus infection. J. Exp. Med. 201:1053-1059.
41. Takaoka, A., Y. Mitani, H. Suemori, M. Sato, Y. Yokochi, S. Noguchi, N. Tanaka, and T. Taniguchi. 2000. Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. Science. 288:2357-2360.
42. Bukowski, J.F., C.A. Biron, and R.M. Welsh. 1983. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus. J. Immunol. 131:991-996.
43. Zajac, A.J., J.N. Blattman, K. Murali-Krishna, D.J. Sourdive, M. Suresh, J.D. Altman, and R. Ahmed. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188:2205-2213.
44. Gallimore, A., A. Glithero, A. Godkin, A.C. Tissot, A. Pluckthun, T. Elliott, H. Hengartner, and R. Zinkernagel. 1998. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187:1383-1393.
45. Missale, G., E. Cariani, and C. Ferrari. 2004. Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies? Dig. Liver Dis. 36:703-711.
46. Dondi, E., L. Rogge, G. Lutfalla, G. Uze, G, and S. Pellegrini. 2003. Down-modulation of responses to type I IFN upon T cell activation. J. Immunol. 170:749-756.
47. Tanabe, Y., T. Nishibori, L. Su, R.M. Arduini, D.P. Baker, and M. David. 2005. Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes. J. Immunol. 174:609-613.
48. Sangfelt, O., S. Erickson, and D. Grander. 2000. Mechanisms of interferon-induced cell cycle arrest. Front Biosci. 5:D479-D487.
49. Schluns, K.S., and L. Lefrancois. 2003. Cytokine control of memory T-cell development and survival. Nat. Rev. Immunol. 3:269-279.
50. Becker, T.C., E.J. Wherry, D. Boone, K. Murali-Krishna, R. Antia, A. Ma, and R. Ahmed. 2002. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. Med. 195:1541-1548.
51. Takaoka, A., S. Hayakawa, H. Yanai, D. Stoiber, H. Negishi, H. Kikuchi, S. Sasaki, K. Imai, T. Shibue, K. Honda, and T. Taniguchi. 2003. Integration of interferon-alpha/beta signaling to p53 responses in tumour suppression and antiviral defence. Nature. 424:516-523.
52. Petricoin, E.F., III, S. Ito, B.L. Williams, S. Audet, L.F. Stancato, A. Gamero, K. Clouse, P. Grimley, A. Weiss, J. Beeler, et al. 1997. Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling. Nature. 390:629-632.
53. Liu, L., H. Parekh-Olmedo, and E.B. Kmiec. 2003. The development and regulation gene repair. Nat. Rev. Genet. 4:679-689.